The American Diabetes Association (ADA)“Standards of Care in Diabetes” includes the
ADA's current clinical practice recommendations and is intended to provide the components …

Abstract Purpose of Review Hypoglycemia is the most common and often treatment-limiting
serious adverse effect of diabetes therapy. Despite being potentially preventable …

Background Among patients with type 2 diabetes, minority racial/ethnic groups have a
higher burden of cardiovascular disease, chronic kidney disease, and hypoglycaemia …

Background: The Tandem Control-IQ (CIQ) system has demonstrated significant glycemic
improvements in large randomized controlled and real-world trials. Use of this system is …

Importance Severe hypoglycemia is a serious and potentially preventable complication of
diabetes, with some of the most severe episodes requiring emergency department (ED) care …

OBJECTIVE 1) To examine trends in the use of diabetes medications and 2) to determine
whether physicians individualize diabetes treatment as recommended by the American …

Aims To compare the real‐world effectiveness of insulin degludec (degludec) and glargine
300 units/mL (glargine U300) in insulin‐naïve adult patients with type 2 diabetes in routine …

The goal of diabetes care is to achieve and maintain good glycemic control over time, so as
to prevent or delay the development of micro-and macrovascular complications in type 1 …

Objective People with type 2 diabetes on insulin are at risk for hypoglycemia. Recurrent
hypoglycemia can cause impaired awareness of hypoglycemia (IAH), and increase the risk …

Hypoglycaemia is a complication associated with the management of both type 1 and type 2
diabetes. Despite newer technologies to help minimize the risk of hypoglycaemia, it remains …